WESPAC Advisors’s Chemed CHE Stock Holding History

WESPAC Advisors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,269	Closed	-$1.78M	–	101
2019 Q3	$1.78M	Buy	+4,269	New	+$1.74M	1.78%	23

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

WESPAC Advisors's CHE Position: Q4 2019 in Review

WESPAC Advisors sold out of Chemed (CHE) in Q4 2019, closing a stake of 4,269 shares — an estimated $1.78M sold.

WESPAC Advisors first reported a position in CHE in Q3 2019 and held it in 1 quarter. The position peaked at $1.78M in Q3 2019. 415 funds tracked by Wall St. Rank hold CHE as of Q4 2019.

WESPAC Advisors reported no remaining Chemed position as of Q4 2019 after selling out during the quarter.
WESPAC Advisors sold 4,269 Chemed shares in Q4 2019, an estimated $1.78M.
WESPAC Advisors first reported a position in Chemed in Q3 2019 and held it in 1 quarter.
WESPAC Advisors's Chemed position peaked at $1.78M in Q3 2019.
415 funds tracked by Wall St. Rank held Chemed as of Q4 2019.

Based on WESPAC Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.